HOME >> MEDICINE >> NEWS
High-dose chemotherapy may improve survival for women with advanced breast cancer

In the 1990s, a number of trials found that treatment with high-dose chemotherapy after conventional chemotherapy did not improve overall survival for women with breast cancer at high-risk of spreading. However, in the latest trial, involving 403 patients with advanced breast cancer, Ulrike Nitz (University of Dusseldorf, Germany) and colleagues found that a rapidly cycled tandem high-dose chemotherapy regimen improved both event-free and overall survival when compared with conventional dose-dense chemotherapy. After 4 years event-free survival was 60% in the high-dose chemotherapy group and 44% in the conventional chemotherapy group. The corresponding overall survival was 75% and 70%, respectively.

Professor Nitz states: "Our finding of significant improvements in both event-free and overall survival for high-dose chemotherapy compared with a dose-dense conventional regimen contrasts with the results of other studies...The heterogeneous [different] designs of the trials that have been conducted to date have not allowed identification of a single promising strategy. Nevertheless, the superiority of high-dose chemotherapy in our trial suggests that this strategy remains valid for further investigation."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
1-Dec-2005


Page: 1

Related medicine news :

1. High-dose anticlotting drug cuts heart attack, death risk in half
2. High-dose flu vaccines appear to safely boost immunity in elderly
3. High-dose vitamin C as a cancer therapy
4. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
5. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
6. Brain-boosting pill alleviates post-chemotherapy fogginess
7. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
8. Most pediatric chemotherapy mistakes reach patients
9. Growth factors given with chemotherapy associated with increased risk of blood diseases
10. Clear guidelines on oral chemotherapy needed
11. Survey reveals need for standardized oral chemotherapy prescribing practices, safeguards

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... ... framework agreements with China Resources Microelectronics Limited (CR Micro) and China Resources ... the possibility of establishing two joint research centres for novel micro-electronic devices ...
(Date:11/15/2018)... ... November 15, 2018 , ... ... Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) have elected Edward D. Buckingham, ... in the specialty field of facial plastics and reconstruction, while AAFPRS is an ...
(Date:11/15/2018)... ... 15, 2018 , ... Over the last decade, SABRE , the global ... for National Breast Cancer Foundation (NBCF) . A mission-driven organization and proud partner ... proceeds have helped launch the National Mammography Program which has provided almost ...
(Date:11/15/2018)... ... November 15, 2018 , ... ApriaDirect, ... now accepts Flexible Spending Account (FSA) and Health Savings Account (HSA) debit cards ... burden of healthcare spending for customers and improve the overall shopping experience. ...
(Date:11/15/2018)... ... November 15, 2018 , ... The National Cancer Institute estimates that 1.7 million ... primary risk factor for cancer and we typically associate the disease with old age, ... And with aggressive treatment and advanced therapies, increasing numbers of these patients survive their ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... November 16, 2018 , ... Drake’s Organic Spirits ... Certification by the globally-recognized and respected Vegan Awareness Foundation. Drake’s is the ... Vegan, Non-GMO Project Verified, Gluten-Free and Kosher. , Many consumers assume ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... Ric Henry, ... Health Care Center in Truth or Consequences, New Mexico on Friday, November 2, 2018. ... President of the Center’s Board of Directors. , Sierra Health Care Center has ...
(Date:11/15/2018)... ... November 15, 2018 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that Pete Young, Director of ... Partnerships in Clinical Trials (PCT) conference at the CCIB Convention Centre Barcelona, Barcelona, ...
Breaking Medicine Technology:
Cached News: